Ticker LaunchUplisting · NXGL
Nexgel, Inc.
Formerly NEXGEL, INC.; AquaMed Technologies, Inc.
Nexgel, Inc. (NXGL), already reporting to the SEC, moved up to Nasdaq Capital Market on Dec 27, 2021 with an offering at $5.50 per share raising $14.2M. Maxim Group was lead-left underwriter. Quick Law Group advised the company and Ellenoff Grossman & Schole advised the underwriters.
NEXGEL, INC. manufactures high water content, electron beam cross-linked aqueous polymer hydrogels used in wound care, medical diagnostics, transdermal drug delivery and cosmetics. It has been a contract manufacturer supplying gels to third parties and has recently begun producing its own branded and white label consumer products.
- Status
- Uplisting
- Ticker
- NXGL
- Exchange
- Nasdaq Capital Market
- Listed
- Dec 27, 2021
- Price
- $5.50
- Raised
- $14.2M
- Market cap at IPO price
- $30.6M
- First filed
- Jan 9, 2019
- Underwriters
- Maxim Group
- Company counsel
- Quick Law Group
- Underwriters' counsel
- Ellenoff Grossman & Schole
- Sector
- Healthcare
- Country / state
- PA
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jan 9, 2019
- Latest amendment Dec 10, 2021
- Final prospectus (424B4) Dec 27, 2021
- All filings on EDGAR CIK 1468929
Other Healthcare uplistings in 2021
- BioRestorative Therapies, Inc.BRTXD · Nov 9, 2021 · $23M
- NutriBand Inc.NTRB · Oct 5, 2021 · $6.6M
- PetVivo Holdings, Inc.PETV · Aug 13, 2021 · $11.2M